Biosafety issues in lentivector production

Current Topics in Microbiology and Immunology

Volumn 261, Issue , 2002, Pages 123-141

  Delenda, C ^a   Audit, M ^a   Danos, O ^a  

^a GÉNÉTHON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ACUTE TOXICITY; BIOSAFETY; CELL LINE; IMMUNOGENICITY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; VIRUS PURIFICATION; VIRUS REPLICATION;

CELL LINE; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; SAFETY; VIRUS REPLICATION;

LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0036206210     PISSN: 0070217X     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-56114-6_6     Document Type: Review

References (96)

1. Identification of a packaged cellular mRNA in virions of rous sarcoma virus
2. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
3. Coupled effects of polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors
4. Specificity of retroviral RNA packaging
5. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines
6. A high affinity binding site for the HIV-1 nucleocapsid protein
7. Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions
8. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations
9. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
10. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses
11. Vial protein R of HIV-1
12. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family
13. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific
14. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles
15. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells
16. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system
17. Lentiviral-mediated gene transfer into human lymphocytes: Role of HIV-1 accessory proteins
18. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein
19. Fusion from without directed by human immunodeficiency virus particles
20. A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity
21. Tissue-specific expression of functionally rearranged lamda 1 Ig gene through a retrovirus vector
22. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
23. ψ-vectors: Murine leukemia virus-based self-inactivating and self activating retroviral vectors
24. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
25. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines
26. A third-generation lentivirus vector with a conditional packaging system
27. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
28. Acquisition of host cell-surface-derived molecules by HIV-1
29. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
30. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors
31. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector
32. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
33. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles
34. Genetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination
35. An association between globin messenger RNA and 60S RNA derived from Friend leukemia virus
36. Self-inactivating lentiviral vectors with U3 and U5 modifications
37. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase
38. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development
39. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
40. A packaging cell line for lentivirus vectors
41. The HIV-1 gag precursor is processed via two pathways: Implications for cytotoxicity
42. Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences
43. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
44. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
45. A stable system for the high-titer production of multiply attenuated lentiviral vectors
46. Lentiviral gene transfer to the nonhuman primate brain
47. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene
48. Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3
49. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells
50. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
51. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element
52. Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev
53. Novel bovine lentiviral vectors based on Jembrana disease virus
54. Stable gene transfer to the nervous system using a non-primate lentiviral vector
55. Development of a self-inactivating lentivirus vector
56. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
57. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
58. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: Evidence for a role in genomic RNA encapsidation
59. Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors
60. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
61. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
62. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus
63. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions
64. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
65. Efficient lentiviral transduction of liver requires cell cycling in vivo
66. The downregulation of CD4 and MHC-1 by primate lentiviruses: A paradigm for the modulation of cell surface receptors
67. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors
68. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
69. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine
70. Molecular biology and pathogenicity of mycoplasmas
71. Production and concentration of pseudotyped HIV-1-based gene transfer vectors
72. HIV-1 Gag protein associates with F-actin present in microfilaments
73. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA
74. Foamy virus vectors
75. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1
76. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
77. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors
78. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus
79. International conference on harmonization; guidance on quality of biotechnological/biological products: Derivation and characterization of cell substrates used for production of biotechnological/biological products: Availability
80. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
81. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
82. Mechanism of transduction by retroviruses
83. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
84. Detection of mycoplasma contaminations in cell cultures by PCR analysis
85. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice
86. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors
87. Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells
88. Evaluation of recommandations for replication competent retrovirus testing associated with use of retroviral vectors
89. Development of a novel trans-lentiviral vector that affords predictable safety
90. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein
91. Inducible human immunodeficiency virus type 1 packaging cell lines
92. HIV-1 genome nuclear import is mediated by a central DNA flap
93. Mutation of polyadenylation signals generates murine retroviruses that produce fused virus-cell RNA transcripts at high frequency
94. Woodchuck hepatitis virus post-transcriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
95. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
96. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo